INC Research Launches "Perspectives" Webinar Series Providing Insights from Key Industry Thought Leaders on the Latest Thinking in Clinical Research
Upcoming Series includes Eight Sessions Focusing on Therapeutic Insights, Emerging Issues in Clinical Development and the Latest on FSP Partnerships
Raleigh, NC, Aug. 13, 2012 - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the launch of its "Perspectives" webinar series designed to bring together key industry experts and thought leaders to share the latest insights and best practices on the many facets of clinical research. INC Research thought leaders will participate in discussions along with a well-rounded group of industry experts, to provide valuable and practical knowledge on such topics as therapeutic insights on clinical trial design, emerging issues in clinical development and the latest on Functional Service Provider (FSP) partnerships.
"The 'Perspectives' series is designed to spotlight the latest developments and best practices in clinical research today," said Alistair Macdonald, President, Clinical Development Services, INC Research. "By sharing experiences on the emerging and most impactful areas of clinical research, we will provide practical information that attendees can incorporate in their day-to-day activities, as well as key insights related to broader strategic issues. With exclusive access to industry leaders, attendees will have a unique opportunity to get answers to their most thought-provoking questions on issues that matter most."
INC's "Perspectives" series kicks off Aug. 28 and includes eight one-hour sessions, concluding mid-November with "Regulatory and Ethics Committees in the United States: Perspectives on Pediatrics Clinical Trials." Further reinforcing the Company's therapeutic focus, the webinar series features three therapeutic sessions on wide-ranging topics, including "Early Phase Oncology Transitional Studies," "Microbiology Operations in Infectious Disease Clinical Trials," and "Recent Important Diabetes Studies - Implications for Clinical Practice."
To learn more about "Perspectives" or to register for the upcoming series, visit www.incresearch.com/perspectives.
About INC Research, LLC
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areasand innovative pediatric and women's health trials. The Company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
Contact: Lori Dorer, Media (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
Copyright 2012 ACN Newswire. All rights reserved. www.acnnewswire.com